[go: up one dir, main page]

MX2022002586A - Isomeros de quelatos de manganeso. - Google Patents

Isomeros de quelatos de manganeso.

Info

Publication number
MX2022002586A
MX2022002586A MX2022002586A MX2022002586A MX2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A MX 2022002586 A MX2022002586 A MX 2022002586A
Authority
MX
Mexico
Prior art keywords
isomers
manganese chelates
chelates
manganese
mri
Prior art date
Application number
MX2022002586A
Other languages
English (en)
Inventor
Michael James Rishel
Brian C Bales
Sean R Dinn
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2022002586A publication Critical patent/MX2022002586A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a los isómeros de compuestos quelatos y su uso como agentes de contraste en procedimientos de resonancia magnética (MRI).
MX2022002586A 2019-09-03 2020-09-03 Isomeros de quelatos de manganeso. MX2022002586A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895121P 2019-09-03 2019-09-03
PCT/EP2020/074645 WO2021043926A1 (en) 2019-09-03 2020-09-03 Manganese chelate isomers

Publications (1)

Publication Number Publication Date
MX2022002586A true MX2022002586A (es) 2022-03-22

Family

ID=72356001

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002586A MX2022002586A (es) 2019-09-03 2020-09-03 Isomeros de quelatos de manganeso.

Country Status (21)

Country Link
US (1) US20220315616A1 (es)
EP (2) EP4512815A3 (es)
JP (2) JP7644095B2 (es)
KR (1) KR20220058574A (es)
CN (2) CN114423761B (es)
AU (1) AU2020340541A1 (es)
BR (1) BR112022003242A2 (es)
CA (1) CA3152191A1 (es)
DK (1) DK4025259T3 (es)
ES (1) ES3010301T3 (es)
FI (1) FI4025259T3 (es)
HR (1) HRP20250045T1 (es)
HU (1) HUE069750T2 (es)
LT (1) LT4025259T (es)
MX (1) MX2022002586A (es)
PL (1) PL4025259T3 (es)
PT (1) PT4025259T (es)
RS (1) RS66436B1 (es)
SI (1) SI4025259T1 (es)
SM (1) SMT202500026T1 (es)
WO (1) WO2021043926A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
EP4464708A1 (en) 2023-05-17 2024-11-20 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO331773B1 (no) 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
PT3770160T (pt) * 2018-08-06 2023-02-21 Bracco Imaging Spa Agentes de contraste à base de pcta que suportam gadolínio
CN114105983B (zh) * 2021-11-09 2023-08-11 国科温州研究院(温州生物材料与工程研究所) 手性1,4,7,10-四氮杂-2,6-吡啶环蕃衍生物及其金属螯合物的制备和应用

Also Published As

Publication number Publication date
CN114423761B (zh) 2024-09-24
PT4025259T (pt) 2025-01-24
WO2021043926A1 (en) 2021-03-11
KR20220058574A (ko) 2022-05-09
JP2022546554A (ja) 2022-11-04
US20220315616A1 (en) 2022-10-06
AU2020340541A1 (en) 2022-04-21
HUE069750T2 (hu) 2025-04-28
PL4025259T3 (pl) 2025-03-03
SMT202500026T1 (it) 2025-03-12
RS66436B1 (sr) 2025-02-28
BR112022003242A2 (pt) 2022-05-17
EP4512815A3 (en) 2025-05-07
EP4025259B1 (en) 2024-10-30
CN119080772A (zh) 2024-12-06
JP7644095B2 (ja) 2025-03-11
CN114423761A (zh) 2022-04-29
EP4025259A1 (en) 2022-07-13
EP4512815A2 (en) 2025-02-26
ES3010301T3 (en) 2025-04-02
LT4025259T (lt) 2025-02-10
DK4025259T3 (da) 2025-01-20
JP2025069163A (ja) 2025-04-30
CA3152191A1 (en) 2021-03-11
FI4025259T3 (fi) 2025-01-13
SI4025259T1 (sl) 2025-03-31
HRP20250045T1 (hr) 2025-03-14

Similar Documents

Publication Publication Date Title
ECSP23070062A (es) Nuevo agente de contraste para utilizar en imágenes por resonancia magnética
ECSP17080394A (es) Nuevos compuestos de quelato de gadolinio para usar en imágenes de resonancia magnética
MX2018007043A (es) Agentes de contraste dimericos.
EP4084696A4 (en) Deoxyhemoglobin in magnetic resonance imaging
MX2018016082A (es) Compuestos quelatos.
CO7121325A2 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
MX2017002703A (es) Sondas para la proyección de imagen de la proteína huntingtina.
CR20180320A (es) Compuestos inhibidores de la quinasa de union a tank
MX385158B (es) Derivados indol para uso en medicina.
CR10654A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados
EA201691044A1 (ru) Новый октагидро-циклобута[1,2-c;3,4-c']дипиррол-2-ил
MX2022002586A (es) Isomeros de quelatos de manganeso.
UY37500A (es) Nuevos compuestos de quelato de gadolinio con alta relaxividad para usar en la obtencion de imagenes por resonancia magnetica
CR20110133A (es) Derivados de piperazina que se unen a las placas amiloides para obtener imágenes de las mismas y su uso
MX2019007595A (es) Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.
EP3512570C0 (en) NEW LIPOSOMAL GADOLINIUM (GD) CONTRAST AGENT FOR T1 MRI
UY29664A1 (es) Complejos metalicos con contenido de prfluoroalquilo procedimientos para su preparacion, a´si como su uso
AR132722A1 (es) Nuevos agentes de contraste para usar en el diagnóstico por imágenes
GB2599535B (en) Novel magnetic resonance imaging contrast agents
IL285659A (en) Nuclear magnetic resonance communication device
AR116002A2 (es) Compuestos intermediarios para la preparación de prolinas macrocíclicas con actividad inhibitoria de las proteasas de serina del vhc
GT201400024A (es) Derivados de n-(5-fluoro-2-((4-metilbencil)oxi)pirimidin-4-il) benzamida
RU2013145233A (ru) МАГНИТОМЕТРИЧЕСКИЙ СПОСОБ ДИАГНОСТИКИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ С ПОМОЩЬЮ НАНОЧАСТИЦ Yb-ПОРФИРИНОВОГО КОМПЛЕКСА
DOP2009000036A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados